GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Atricure, Inc. (ATRC) [hlAlert]

Rating:
Outperform
ATRC
up 109.65 %

Atricure, Inc. (ATRC) rated Outperform with price target $14 by Barrington Research

Posted on: Tuesday,  Jan 4, 2011  9:25 AM ET by Barrington Research

Barrington Research rated Outperform Atricure, Inc. (NASDAQ: ATRC) on 01/04/2011. Previously Barrington Research rated Outperform Atricure, Inc. (NASDAQ: ATRC) on 12/19/2007.,
when the stock price was $12.53. Since then, Atricure, Inc. has gained 109.66% as of 01/06/2016's recent price of $26.27.
If you would have followed the previous Barrington Research's recommendation on ATRC, you would have gained 109.65% of your investment in 2940 days.

AtriCure, Inc. is a medical device company that develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. The Company's primary product line, which accounts for a majority of its revenues, is the AtriCure Isolator system. AtriCure's Isolator system consists primarily of a compact power generator known as an ablation and sensing unit (ASU), a switchbox unit (ASB), which allows physicians to toggle between multiple products and multiple configurations of its Isolator clamps, including its Isolator Synergy clamps. AtriCure also sells a multifunctional bipolar pen, or multifunctional pen, which is often used by physicians in combination with its Isolator system to ablate cardiac tissue and for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias. In 2008, The Company received FDA approval for its EXCLUDE clinical trial.

As our name implies, research plays a central role in everything we do. Whether we're dealing with sales, trading, investment banking or asset management, insightful research is indispensable in providing value to our clients. Our research provides us with a comprehensive understanding of the economy, financial markets, and individual companies, all of which are essential in recommending successful investments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/4/2011 9:25 AM Buy
None
10.52 14.00
as of 12/30/2011
1 Week down  -5.29 %
1 Month up  9.46 %
3 Months up  13.96 %
1 YTD up  8.08 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/19/2007 8:25 AM Buy
None
12.53 17.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy